Purpose To report the long-term outcomes of amniotic membrane (AM) use in the form of
transplantation (AMT) and self-retained amniotic membrane (ProKera® device, PD) in acute …

Purpose To describe the clinical course, treatments, and outcomes of 10 consecutive
patients treated with amniotic membrane transplantation (AMT) applied to the eyelid …

Purpose: To evaluate the indications and outcomes of amniotic membrane transplantation
(AMT) performed within the first 2 weeks of presentation in the management of patients with …

PURPOSE: To describe the results of a novel treatment approach to the acute ophthalmic
management of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) …

Background Stevens-Johnson syndrome is often associated with blinding ocular surface
cicatricial sequelae. Recent reports have described markedly improved clinical outcomes …

Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, have
relatively low overall incidence; however, this disease presents with high morbidity and …

Purpose To evaluate the adjuvant role of amniotic membrane transplantation (AMT) in cases
of acute ocular Stevens–Johnson syndrome (SJS). Design Prospective randomized …

Purpose To describe the long-term effect of a treatment protocol for ocular involvement in
acute Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), including focused …

Purpose To describe a new grading system and associated treatment guidelines for the
acute ocular manifestations of Stevens-Johnson syndrome (SJS) and toxic epidermal …

Cryopreserved amniotic membrane (AM) transplantation is an emerging technique that is
becoming the gold standard for the management of acute Stevens-Johnson syndrome (SJS) …